by AIP Online Bureau | May 19, 2024 | Indian News, Regulation, Risk Management
As per the USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote New...
by AIP Online Bureau | Aug 15, 2022 | Eco/Invest/Demography, Health, Indian News, Non-Life, Reinsurance
The affected lot has been produced at the company’s Halol plant in Gujarat and distributed in the US by Cranbury-based Sun Pharmaceutical Industries, Inc New Delhi: Leading generic drug makers Glenmark, Sun Pharma, Dr Reddy’s and Jubilant Cadista are...
